Etoposide and Insulin Aspart Protamine Injection
Determining the interaction of Etoposide and Insulin Aspart Protamine Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: etoposide
Brand name: VePesid, Etopophos, Toposar
Synonyms: n.a.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Etoposide-Insulin aspart, recombinant Subcutaneous
- Etoposide-Insulin degludec
- Etoposide-Insulin Degludec (U-100) Prefilled Pens
- Etoposide-Insulin Degludec (U-100) Vials
- Etoposide-Insulin Degludec (U-200) Prefilled Pens
- Etoposide-Insulin degludec and liraglutide
- Insulin Aspart Protamine Injection-Etoposide Capsule
- Insulin Aspart Protamine Injection-Etoposide Capsules
- Insulin Aspart Protamine Injection-Etoposide injection
- Insulin Aspart Protamine Injection-Etoposide Oral, Intravenous
- Insulin Aspart Protamine Injection-Etoposide phosphate
- Insulin Aspart Protamine Injection-Etrafon